logo
  • Nonprofit News
  • Management
    • Boards and Governance
    • Communication
      • Framing & Narratives
    • Ethics
    • Financial Management
    • Grassroots Fundraising Journal
    • Leadership
    • Technology
  • Philanthropy
    • Corporate Social Responsibility
    • Donor-Advised Funds
    • Foundations
    • Impact Investing
    • Research
    • Workplace Giving
  • Policy
    • Education
    • Healthcare
    • Housing
    • Government
    • Taxes
  • Economic Justice
    • About
    • Economy Remix
    • Economy Webinars
    • Community Benefits
    • Economic Democracy
    • Environmental Justice
    • Fair Finance
    • Housing Rights
    • Land Justice
    • Poor People’s Rights
    • Tax Fairness
  • Racial Equity
  • Social Movements
    • Community Development
    • Community Organizing
    • Culture Change
    • Education
    • Environment
    • Gender Equality
    • Immigrant Rights
    • Indigenous Rights
    • Labor
    • LGBTQ+
    • Racial Justice
    • Youth Activism
  • About Us
  • Log in
  • CONTENT TYPES
  • Featured Articles
  • Webinars
    • Free Webinars
    • Premium On-Demand Webinars
  • Tiny Spark Podcast
  • Magazine
    • Magazine
    • Leading Edge Membership
Donate
Management, Methadone/Safe Injection Clinics, Opioid Crisis

Massachusetts Sues Sackler Family Board Members as Part of Opioid Lawsuit

Steve Dubb
June 18, 2018
Share39
Tweet16
Email
Share
“No OC for You,” RedFishingBoat (Mike O.)

June 16, 2018; NBC News

Massachusetts Attorney General Maura Healey named eight Sackler family members as defendants this week in a complaint that accused Purdue Pharma of spinning a “‘web of illegal deceit’ to boost profits,” notes NBC News. The complaint also names eight executives.

As NPQ has covered, Purdue Pharma is owned by the descendants of Mortimer and Raymond Sackler, a family with an estimated net worth of $13 billion. OxyContin, adds NBC News, has generated more than $35 billion in revenue for Purdue Pharma since 1995. A large portion of the Sackler family fortune is due to profits earned from the drug.

In its complaint, the attorney general’s office summarizes its rationale for naming Sackler family members and Purdue Pharma directors as personally liable.

The directors and CEOs had oversight and control over the unlawful sales and marketing conduct at issue in this Complaint, and they are personally liable for the misconduct because: (a) they participated in the misconduct; and/or (b) they knew about the misconduct and failed to stop it; and/or (c) they should have known about the misconduct and they failed to stop it. In this case, the directors and CEOs are personally liable for all three reasons.

In addition to providing supporting evidence to buttress the above assertion, the lawsuit identifies three primary causes of action as the rationale for establishing Purdue Pharma’s and its codefendants’ legal liability: 1) unfair and deceptive acts and practices, 2) public nuisance, and 3) negligence. These causes of action broadly reflect the claims made in many of the 200-plus lawsuits filed by other states, local governments, and American Indian nations to date. In Cleveland, Ohio, federal judge Dan Aaron Polster is overseeing a process that aims to consolidate these cases and pushing for a settlement. An initial trial date, however, has been set for March 18, 2019.

Sackler-owned Purdue patented the drug OxyContin and played a large role in the production, sale, and marketing of the drug. According to the federal Centers for Disease Control and Prevention, prescribed opioids alone are estimated to be responsible for the deaths of over 200,000 Americans since 1999, with 2016 fatality levels five times higher than 1999 levels.

According to Healey’s lawsuit, in Massachusetts, over 11,000 have died from opioid-related overdoses in the past decade. And, in Massachusetts, as in the nation, opioid-related fatalities have been rising—from 590 in 2010 to 2,155 in 2016, before falling slightly to 1,977 in 2017.

Writing in the Guardian, Joanna Walters notes, “The Sacklers being sued are: Theresa and Beverly, the widows of the brothers Mortimer and Raymond Sackler who built the company into the narcotics giant it is today; Ilene, Kathe and Mortimer David Alfons Sackler, three of Mortimer’s children; Jonathan and Richard Sackler, Raymond’s two sons; and David Sackler, Raymond’s grandson.” (Descendants of Arthur Sackler, the older brother of Mortimer and Raymond, are not named in the lawsuit, as Arthur passed away before OxyContin was invented and the other two brothers bought out his estate’s interest shortly after Arthur’s death.)

The suit filed by Massachusetts doesn’t name a dollar figure, but NBC News notes that, “Healey asked a judge to order the Sacklers and Purdue to ‘pay full and complete restitution to every person who has suffered any ascertainable loss by reason of their unlawful conduct.’”

Mike Moore, a former Mississippi attorney general who was a central figure in the state tobacco lawsuits two decades ago and is also involved in the current opioid litigation, calls Healey’s decision to name the Sacklers as defendants. “a brilliant legal strategy.”

Moore says that naming the Sacklers “pulls up the corporate curtain of protection that these people hide behind. The Sacklers personally made billions of dollars while tens of thousands of overdose deaths were occurring as a direct result of their lies about the addictiveness and effectiveness of OxyContin, the drug they created and marketed. Just as these folks like to be honored when they write big checks to museums and have their names inscribed on plaques for their contributions to so many causes, they should be held accountable for how they made that money in the first place.”

Emalie Gainey, a spokeswoman for Healey, notes that naming the Sacklers was done “to hold them individually liable for the role we allege they played.” At a press conference, Healey herself points out that, “Not only did we name the company today, but we’ve also chose to name executives and directors. Ours is the first lawsuit in the country to name those executives personally and tell the story of how they contributed to this deadly crisis.”—Steve Dubb

Share39
Tweet16
Email
Share

About The Author
Steve Dubb

Steve Dubb is a senior editor at NPQ, where he directs NPQ’s economic justice program, including NPQ’s Economy Remix column. Steve has worked with cooperatives and nonprofits for over two decades, including twelve years at The Democracy Collaborative and three years as executive director of NASCO (North American Students of Cooperation). In his work, Steve has authored, co-authored and edited numerous reports; participated in and facilitated learning cohorts; designed community building strategies; and helped build the field of community wealth building. Steve is the lead author of Building Wealth: The Asset-Based Approach to Solving Social and Economic Problems (Aspen 2005) and coauthor (with Rita Hodges) of The Road Half Traveled: University Engagement at a Crossroads, published by MSU Press in 2012. In 2016, Steve curated and authored Conversations on Community Wealth Building, a collection of interviews of community builders that Steve had conducted over the previous decade.

Related
Overdose Deaths Appear to Spike in Pandemic’s Wake
By Ruth McCambridge
December 4, 2020
McKinsey’s Values-less Consulting: Time for Philanthropy to Cut Them Loose?
By Martin Levine
December 2, 2020
Pandemic Appears to Bring Out the Ugly in Profiteering Pharma Execs
By Ruth McCambridge
November 12, 2020
Pfizer Announces Positive Results from Vaccine Trials
By Karen Kahn
November 11, 2020
Before We Celebrate the Purdue Pharma Settlement…
By Ruth McCambridge
October 23, 2020
The COVID Vaccine “War”: Screws Loose in our Moral Framework
By Karen Kahn
August 14, 2020

Upcoming Webinars

Group Created with Sketch.
January 21, 2 pm ET

Remaking the Economy

Health, Racial Disparities, and Economic Justice

other posts by The Author
Out of View, Exiting Administration Wields Its Axe at the...
By Steve Dubb
January 15, 2021
Feds Fix Some PPP Flaws but Ignore Old Shortcomings
By Steve Dubb
January 13, 2021
The Long Road to Cultural Representation: Two New...
By Steve Dubb
January 12, 2021
CYNDI SUAREZ
The Nonprofit Racial Leadership Gap: Flipping the Lens
Powerful Interests Seek to Make Puerto Rico the Hong Kong of the...
Moving Beyond the Privilege of White Tears